Regeneus
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WARegeneus Limited (RGS) is a Sydney based regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases.
Contact Details
2 Paddington Street, PADDINGTON NSW 2021
02 9499 8010
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 1006th |  | Regeneus | $1.1m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| NEWS: Tagged in Regeneus trebles on back of merger deal | 05 Apr 2024 |
| NEW ROLE: John Chiplin, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Graham Vesey, Chief Scientific Officer, Executive Director | 03 Nov 2020 |
| NEW ROLE: Alan Dunton, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Leo Lee, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Sandra McIntosh, Company Secretary | 03 Nov 2020 |
| NEW ROLE: Karolis Rosickas, Chief Executive Officer | 03 Nov 2020 |
| NEW ROLE: Barry Sechos, Non-Executive Director, Chair since 2019 | 03 Nov 2020 |
